BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference
November 20, 2020 08:30 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
November 11, 2020 08:30 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
BioDelivery Sciences Reports Strong Q3 2020 Results
November 05, 2020 08:00 ET
|
BioDelivery Sciences International
Total Company Net Revenue Increased 30% versus Prior Year Reaching a Record $39.4 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE)...
BioDelivery Sciences Announces $25 Million Share Repurchase Program
November 04, 2020 17:31 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
BioDelivery Sciences Announces Appointment of Jeff Bailey as Permanent CEO
November 04, 2020 17:11 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
BioDelivery Sciences to Report Third Quarter 2020 Financial Results on November 5, 2020
October 23, 2020 08:00 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Oct. 23, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
BioDelivery Sciences Announces Five Scientific Poster Presentations at PAINWeek® 2020 National Conference on Pain Management
September 11, 2020 08:00 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Sept. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with...
BioDelivery Sciences to Present at Two Upcoming Investor Conferences
September 03, 2020 08:00 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Sept. 03, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with...
BioDelivery Sciences Reports Strong Q2 2020 Results
August 05, 2020 07:45 ET
|
BioDelivery Sciences International
Second Quarter Total Company Net Revenue Increased 23% versus Prior Year to $36.6 Million Second Quarter BELBUCA® Net Sales Increased 34% versus Prior Year to $32.3 Million BELBUCA and Symproic®...
BioDelivery Sciences to Report Second Quarter 2020 Financial Results on August 5, 2020
July 27, 2020 16:01 ET
|
BioDelivery Sciences International
RALEIGH, N.C., July 27, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...